(Total Views: 898)
Posted On: 11/24/2020 10:22:52 AM
Post# of 149086
From amfar wiki page:
https://en.m.wikipedia.org/wiki/AmfAR,_The_Fo...S_Research
National initiatives: ...
In November 2020, amfAR signed an agreement with CytoDyn Inc. to explore the potential of its CCR-5 antagonist Vyrologix (Leronlimab) to mediate a functional HIV cure. According to Kevin Robert Frost, Chief Executive Officer at amfAR, "demonstrating that Leronlimab can functionally phenocopy CCR5 deficiency and replicate the London and Berlin patients would be a major advancement.”[61]
https://en.m.wikipedia.org/wiki/AmfAR,_The_Fo...S_Research
National initiatives: ...
In November 2020, amfAR signed an agreement with CytoDyn Inc. to explore the potential of its CCR-5 antagonist Vyrologix (Leronlimab) to mediate a functional HIV cure. According to Kevin Robert Frost, Chief Executive Officer at amfAR, "demonstrating that Leronlimab can functionally phenocopy CCR5 deficiency and replicate the London and Berlin patients would be a major advancement.”[61]
(2)
(0)Scroll down for more posts ▼
